Streetbeat News

Analyst Ratings

E

Redburn Atlantic analyst Peter Low has upgraded Eni (NYSE:E) from Neutral to Buy.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:48 am

KROS

Oppenheimer has initiated coverage on Keros Therapeutics (NASDAQ:KROS) with an Outperform rating and a price target of $102.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:45 am

ZETA

RBC Capital has initiated coverage on Zeta Global Holdings (NYSE:ZETA) with an Outperform rating and a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:44 am

CLSD

Oppenheimer has initiated coverage on Clearside Biomedical (NASDAQ:CLSD) with an Outperform rating and a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:43 am

GOSS

Oppenheimer has initiated coverage on Gossamer Bio (NASDAQ:GOSS) with an Outperform rating and set a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:40 am

CRDO

TD Cowen has upgraded Credo Technology Group (NASDAQ:CRDO) from Hold to Buy and raised the price target from $24 to $35, according to analyst Matt Ramsay.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:35 am

BIRK

Morgan Stanley analyst Edouard Aubin maintains an Equal-Weight rating on Birkenstock Holding (NYSE:BIRK) and raises the price target from $44 to $58.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:31 am

HRMY

Needham analyst Ami Fadia reiterates a Buy rating on Harmony Biosciences (NASDAQ:HRMY) and maintains a $52 price target.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:30 am

ALNY

Morgan Stanley analyst Michael Ulz maintains an Equal-Weight rating on Alnylam Pharmaceuticals (NASDAQ:ALNY) and raises the price target from $164 to $250.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:29 am

SE

JP Morgan analyst Ranjan Sharma has downgraded Sea (NYSE:SE) from Overweight to Neutral and lowered the price target from $84 to $78.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:21 am